Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
May 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Femasys received CE Mark approval for its FemHSG Catheter, expanding the company's fertility diagnostics portfolio into the European market.
Mar 20, 2024
FemaSeed: A Breakthrough Solution Proving Promise in Overcoming Infertility Challenges
CSIMarket
Read ↗
Mar 20, 2024
FemaSeed Shows Positive Results for Infertility Treatment
Contemporary OB/GYN
Read ↗
Mar 20, 2024
Femasys Announces Positive Topline Data from Pivotal Trial for FDA-Cleared FemaSeed
Femasys IR
Read ↗
Mar 20, 2024
Femasys Discloses Positive Data from FemaSeed Trial
The Wall Street Journal
Read ↗
Mar 6, 2024
Femasys Completes First In-Office Commercial Procedure with FDA-Cleared FemaSeed
GlobeNewswire / Femasys
Read ↗
Feb 28, 2024
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
GlobeNewswire
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.